Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): Yariv Houvras (CHIEF MEDICAL OFFICER): Grant/Award of 105,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Yariv Houvras, CHIEF MEDICAL OFFICER | Grant/Award | 105,000 | n/a |
| Jun 12, 2026 | Akintunde Olatokumbo Bello | Grant/Award | 5,000 | n/a |
| Jun 12, 2026 | James Samuel Shannon | Grant/Award | 5,000 | n/a |
| Jun 12, 2026 | Daniel J. Curran | Grant/Award | 5,000 | n/a |
| Jun 12, 2026 | Yuan Xu | Grant/Award | 5,000 | n/a |
| Jun 12, 2026 | Robert W. Ross | Grant/Award | 5,000 | n/a |
| Jun 12, 2026 | Sara Bonstein | Grant/Award | 5,000 | n/a |
| Jun 12, 2026 | Aoife Brennan | Grant/Award | 5,000 | n/a |
| Apr 16, 2026 | Cheryl R. Blanchard | Grant/Award | 10,000 | n/a |
| Mar 30, 2026 | James Samuel Shannon | Purchase | 5,000 | $43.9K |